Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Sah P, Vilches TN, Moghadas SM, Gondi S, Schneider EC, Singer J, Chokshi DA, Galvani AP, Return on investment of the COVID-19 vaccination campaign in New York City, JAMA Network Open 2022, 5(11): e2243127.
Moghadas SM, Sah P, Shoukat A, Meyers LA, Galvani AP, Population immunity against COVID-19 in the United States, Annals of Internal Medicine 2021, 174(11):1586-1591.
Wells CR, Townsend JP, Pandey A, Moghadas SM, Krieger G, Singer BH, McDonald RH, Fitzpatrick MC, Galvani AP, Optimizing COVID-19 quarantine and testing strategies, Nature Communications 2021, 21: 356.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Shoukat A, Vilches TN, Moghadas SM, Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia, BMC Medicine 2018, 16: 100.
Shoukat A, Van Exan RJ, Moghadas SM, Cost-effectiveness of a potential vaccine candidate for Haemophilus influenzae serotype ‘a’, Vaccine 2018, 36: 1681–1688.
Röst G, Kuniya T, Moghadas SM, Wu J, Global dynamics of an epidemiological model with age-of-infection dependent treatment rate, Ricerche di Matematica 2018, 67: 125–140.
Champredon D, Laskowski M, Charland N, Moghadas SM, Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada, Scientific Reports 2018, 8: 6492.
Champredon D, Najafi M, Laskowski M, Chit A, Moghadas SM, Individual movements and contact patterns in a Canadian long-term care facility, AIMS Public Health 2018, 5: 111–121.
Chen L, Mukerjee G, Dorfman R, Moghadas SM, Disease risk assessment using a Voronoi-based network analysis of genes and variants scores, Frontiers in Genetics 2017, 8: 29.
Moghadas SM, Shoukat A, Espindola A, Pereira RS, Abdirizak F,Laskowski M, Viboud C, Chowell G, Asymptomatic transmission and the dynamics of Zika infection, Scientific Reports 2017, 7: 5829.
Maghdoori S, Moghadas SM, Assessing the effect of patient screening and isolation on curtailing Clostridium difficile infection in hospital settings, BMC Infectious Diseases 2017, 17: 384.
Champredon D, Moghadas SM, Quantifying the contribution of asymptomatic infection to the cumulative incidence, Epidemiology and Infection 2017, 145: 1256–1258.
Moghadas SM, Mathematical modelling of tuberculosis, Mathematical Population Studies 2017, 24: 1-2.